Patients
| Country | Value | Year |
|---|---|---|
| Iraq | 20.1 | 2024 |
| Israel | 21.2 | 2024 |
| Jordan | 34.1 | 2024 |
| Lebanon | 46.9 | 2024 |
| Palestine | 35.5 | 2024 |
| Qatar | 12.5 | 2024 |
| Saudi Arabia | 14.7 | 2024 |
| UAE | 9.0 | 2024 |
Updated
Reviewed by Chandani Patel
Middle East Smoking Cessation Products Market Industry Trends and Forecast to 2034: Segmented by (Product, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$104.0 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $155.5 Mn | — | — |
| 2025 (base) | $164.3 Mn | +$8.7 Mn | — |
| 2026 (forecast) | $173.5 Mn | +$9.2 Mn | +5.6% |
| 2027 (forecast) | $183.2 Mn | +$9.7 Mn | +11.5% |
| 2028 (forecast) | $193.4 Mn | +$10.3 Mn | +17.8% |
| 2029 (forecast) | $204.3 Mn | +$10.8 Mn | +24.4% |
| 2030 (forecast) | $215.7 Mn | +$11.4 Mn | +31.3% |
| 2031 (forecast) | $227.8 Mn | +$12.1 Mn | +38.7% |
| 2032 (forecast) | $240.5 Mn | +$12.8 Mn | +46.4% |
| 2033 (forecast) | $254.0 Mn | +$13.5 Mn | +54.6% |
| 2034 (forecast) | $268.2 Mn | +$14.2 Mn | +63.3% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $164.3 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $268.2 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 5.6% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, form and distribution channel (see all) |
| Key players | Haleon PLC, Johnson & Johnson, Pfizer Inc., Perrigo Company plc, Cipla Inc. (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Smoking cessation products help people quit smoking, including nicotine patches, gums, sprays, medicines and quit apps.
Key segments of the smoking Cessation Products market include product (Nicotine Replacement Therapy, Prescription Drugs and Digital Quit Programs) and form (Patches, Gum and Lozenges and Sprays and Inhalers).
More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the smoking Cessation Products market.
Ready-to-use formulations, biosimilars and supply security programmes give the smoking Cessation Products market room to grow.
Drug shortages, price controls, generic competition and strict hospital budgets hold back the smoking Cessation Products market.
The smoking Cessation Products market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In some of the countries we cover here, medicines are approved by SFDA (Saudi Arabia)[1], EDE (UAE)[2], Ministry of Public Health (Qatar)[3] and Ministry of Health (Israel)[4]. In some of the countries we cover here, supplement rules come from SFDA (Saudi Arabia)[1].
[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.
[2] Emirates Drug Establishment. Checked 14 Nov 2026.
[3] Ministry of Public Health, Qatar. Checked 19 Nov 2026.
[4] Israel Ministry of Health. Checked 19 Nov 2026.
Food and supplement rules, labelling and health-claim regulations govern smoking Cessation Products products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in Middle East.
What doctors and scientists are doing in Smoking Cessation Products right now, from free public sources.
| Country | Value | Year |
|---|---|---|
| Iraq | 20.1 | 2024 |
| Israel | 21.2 | 2024 |
| Jordan | 34.1 | 2024 |
| Lebanon | 46.9 | 2024 |
| Palestine | 35.5 | 2024 |
| Qatar | 12.5 | 2024 |
| Saudi Arabia | 14.7 | 2024 |
| UAE | 9.0 | 2024 |
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 21 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Middle East · 1 shared keyword
Middle East · 1 shared keyword
Middle East · 1 shared keyword
Middle East · 1 shared keyword
Middle East · 1 shared keyword
Middle East · 1 shared keyword
Medical Devices · Middle East
Medical Devices · Middle East
Medical Devices · Middle East
Medical Devices · Middle East
Pharmaceuticals · Middle East
Medical Devices · Middle East